Cleared Traditional

K173933 - Sorrento Bioglass Bone Graft Substitute

K173933 is an FDA 510(k) clearance for Sorrento Bioglass Bone Graft Substitute, manufactured by Xenco Medical, LLC. The device is a Class 2 Orthopedic device with product code MQV cleared through the Traditional 510(k) pathway after a 261-day FDA review.

K173933 · Xenco Medical, LLC · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2018
Decision
261d
Days
Class 2
Risk

K173933 is an FDA 510(k) clearance for the Sorrento Bioglass Bone Graft Substitute. Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.

Submitted by Xenco Medical, LLC (San Diego, US). The FDA issued a Cleared decision on September 13, 2018 after a review of 261 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Xenco Medical, LLC devices

FDA 510(k) Submission Details - K173933

510(k) Number K173933 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 26, 2017
Decision Date September 13, 2018
Days to Decision 261 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
139d slower than avg
Panel avg: 122d · This submission: 261d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MQV Device Classification - Class 2, Special Controls

Product Code MQV Filler, Bone Void, Calcium Compound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MQV Filler, Bone Void, Calcium Compound

All 290
Devices cleared under the same product code (MQV) and FDA review panel - the closest regulatory comparables to K173933.
PRODENSE Bone Graft Substitute
K182823 · Wrightmedicaltechnologyinc · Nov 2018
Osteocera Resorbable Bone Substitute
K180758 · Wiltrom Corporation Limited · Oct 2018
Ceracell Ortho Foam
K181721 · Curasan AG · Sep 2018
BioSphere Flex
K173424 · Synergy Biomedical · Sep 2018
PRODENSE Bone Graft Substitute
K181255 · Wrightmedicaltechnologyinc · Sep 2018
ALTAPORE
K181225 · Baxter Healthcare Corporation · Aug 2018